185 related articles for article (PubMed ID: 15637053)
1. Differential regulation of phosphoglucose isomerase/autocrine motility factor activities by protein kinase CK2 phosphorylation.
Yanagawa T; Funasaka T; Tsutsumi S; Raz T; Tanaka N; Raz A
J Biol Chem; 2005 Mar; 280(11):10419-26. PubMed ID: 15637053
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells.
Funasaka T; Hu H; Yanagawa T; Hogan V; Raz A
Cancer Res; 2007 May; 67(9):4236-43. PubMed ID: 17483335
[TBL] [Abstract][Full Text] [Related]
3. Regulation of phosphoglucose isomerase/autocrine motility factor expression by hypoxia.
Funasaka T; Yanagawa T; Hogan V; Raz A
FASEB J; 2005 Sep; 19(11):1422-30. PubMed ID: 16126909
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of phosphoglucose isomerase/autocrine motility factor expression sensitizes human fibrosarcoma cells to oxidative stress leading to cellular senescence.
Funasaka T; Hu H; Hogan V; Raz A
J Biol Chem; 2007 Dec; 282(50):36362-9. PubMed ID: 17925402
[TBL] [Abstract][Full Text] [Related]
5. Regulation of phosphoglucose isomerase/autocrine motility factor activities by the poly(ADP-ribose) polymerase family-14.
Yanagawa T; Funasaka T; Tsutsumi S; Hu H; Watanabe H; Raz A
Cancer Res; 2007 Sep; 67(18):8682-9. PubMed ID: 17875708
[TBL] [Abstract][Full Text] [Related]
6. Regulation of cell proliferation by autocrine motility factor/phosphoglucose isomerase signaling.
Tsutsumi S; Yanagawa T; Shimura T; Fukumori T; Hogan V; Kuwano H; Raz A
J Biol Chem; 2003 Aug; 278(34):32165-72. PubMed ID: 12783864
[TBL] [Abstract][Full Text] [Related]
7. The enzymatic activity of phosphoglucose isomerase is not required for its cytokine function.
Tsutsumi S; Gupta SK; Hogan V; Tanaka N; Nakamura KT; Nabi IR; Raz A
FEBS Lett; 2003 Jan; 534(1-3):49-53. PubMed ID: 12527360
[TBL] [Abstract][Full Text] [Related]
8. Phosphoglucose isomerase/autocrine motility factor mediates epithelial and mesenchymal phenotype conversions in breast cancer.
Funasaka T; Hogan V; Raz A
Cancer Res; 2009 Jul; 69(13):5349-56. PubMed ID: 19531650
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of phosphoglucose isomerase/autocrine motility factor enhances gensenoside Rh2 pharmacological action on leukemia KG1α cells.
You ZM; Zhao L; Xia J; Wei Q; Liu YM; Liu XY; Chen DL; Li J
Asian Pac J Cancer Prev; 2014; 15(3):1099-104. PubMed ID: 24606425
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblasts.
Tsutsumi S; Hogan V; Nabi IR; Raz A
Cancer Res; 2003 Jan; 63(1):242-9. PubMed ID: 12517804
[TBL] [Abstract][Full Text] [Related]
11. Autocrine motility factor signaling enhances pancreatic cancer metastasis.
Tsutsumi S; Yanagawa T; Shimura T; Kuwano H; Raz A
Clin Cancer Res; 2004 Nov; 10(22):7775-84. PubMed ID: 15570012
[TBL] [Abstract][Full Text] [Related]
12. Phosphohexose isomerase/autocrine motility factor/neuroleukin/maturation factor is a multifunctional phosphoprotein.
Haga A; Niinaka Y; Raz A
Biochim Biophys Acta; 2000 Jul; 1480(1-2):235-44. PubMed ID: 11004567
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase CK2 is an inhibitor of the neuronal Cdk5 kinase.
Lim AC; Hou Z; Goh CP; Qi RZ
J Biol Chem; 2004 Nov; 279(45):46668-73. PubMed ID: 15342635
[TBL] [Abstract][Full Text] [Related]
14. The crystal structure of a multifunctional protein: phosphoglucose isomerase/autocrine motility factor/neuroleukin.
Sun YJ; Chou CC; Chen WS; Wu RT; Meng M; Hsiao CD
Proc Natl Acad Sci U S A; 1999 May; 96(10):5412-7. PubMed ID: 10318897
[TBL] [Abstract][Full Text] [Related]
15. Silencing of autocrine motility factor induces mesenchymal-to-epithelial transition and suppression of osteosarcoma pulmonary metastasis.
Niinaka Y; Harada K; Fujimuro M; Oda M; Haga A; Hosoki M; Uzawa N; Arai N; Yamaguchi S; Yamashiro M; Raz A
Cancer Res; 2010 Nov; 70(22):9483-93. PubMed ID: 20978190
[TBL] [Abstract][Full Text] [Related]
16. Acid-induced conformational changes in phosphoglucose isomerase result in its increased cell surface association and deposition on fibronectin fibrils.
Amraei M; Jia Z; Reboul P; Nabi IR
J Biol Chem; 2003 Oct; 278(40):38935-41. PubMed ID: 12888574
[TBL] [Abstract][Full Text] [Related]
17. AMF/PGI-mediated tumorigenesis through MAPK-ERK signaling in endometrial carcinoma.
Li Y; Jia Y; Che Q; Zhou Q; Wang K; Wan XP
Oncotarget; 2015 Sep; 6(28):26373-87. PubMed ID: 26308071
[TBL] [Abstract][Full Text] [Related]
18. Induction of hepatoma cells migration by phosphoglucose isomerase/autocrine motility factor through the upregulation of matrix metalloproteinase-3.
Yu FL; Liao MH; Lee JW; Shih WL
Biochem Biophys Res Commun; 2004 Jan; 314(1):76-82. PubMed ID: 14715248
[TBL] [Abstract][Full Text] [Related]
19. Novel N-substituted 5-phosphate-d-arabinonamide derivatives as strong inhibitors of phosphoglucose isomerases: Synthesis, structure-activity relationship and crystallographic studies.
Ahmad L; Plancqueel S; Lazar N; Korri-Youssoufi H; Li de la Sierra-Gallay I; van Tilbeurgh H; Salmon L
Bioorg Chem; 2020 Sep; 102():104048. PubMed ID: 32682158
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation by protein kinase CK2 modulates the activity of the ATP binding cassette A1 transporter.
Roosbeek S; Peelman F; Verhee A; Labeur C; Caster H; Lensink MF; Cirulli C; Grooten J; Cochet C; Vandekerckhove J; Amoresano A; Chimini G; Tavernier J; Rosseneu M
J Biol Chem; 2004 Sep; 279(36):37779-88. PubMed ID: 15218032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
